MediGuide™
DeviceMediGuide™ system will be used to guide CRT implants
NCT Number: NCT01519739
The purpose of this study is to evaluate the safety and performance of the MediGuide™ system during CRT implants.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
MediGuide™ system will be used to guide CRT implants
Time frame: 1 month post CRT implant
Performance will be assessed in terms occurence of adverse events, easy of use and potential benefits.
Abbott Medical Devices
Industry
Clinical Evaluation of Mediguide System in CRT Implants
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05750953
Cardiovascular Diseases, Colon Rectal Cancer
Stavanger, Rogaland, Norway
View Trial DetailsNCT02061319
Cardiovascular Diseases, Heart Diseases
Ottawa, Ontario, Canada
View Trial DetailsNCT06576050
Body Weight, Body Weight Changes
Boston, Massachusetts, United States
View Trial DetailsNCT04113109
Cardiovascular Diseases, Heart Diseases
Nashville, Tennessee, United States
View Trial Details